X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
3.26
-0.11 (-3.26%)
At close: May 12, 2025, 2:48 PM
X4 Pharmaceuticals Revenue Breakdown
Period Ending | Dec 31, 2024 |
---|---|
Product Returns Revenue | 11K |
Product Returns Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Mar 31, 2016 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 15.02M | 15.14M | 15.66M | 13.28M | 17.43M | 9.93M | 8.13M | 10.2M | 10.2M | 7.24M | 6.56M | 6.75M | 7.66M | 7.13M | 5.93M | 5.8M | 5.83M | 5.36M | 5.6M | 5.32M | 4.67M | 3.91M | 4.38M | 4.56M | 4.78M | 8.63M | 3.27M | 3.69M | 2.82M | 2.38M | 2.46M | 1.74M | 1.44M | 1.47M | 1.24M |
Selling, General, and Administrative Revenue Growth | -0.82% | -3.29% | +17.94% | -23.84% | +75.63% | +22.06% | -20.30% | 0.00% | +40.92% | +10.33% | -2.76% | -11.94% | +7.41% | +20.30% | +2.19% | -0.48% | +8.87% | -4.32% | +5.32% | +13.83% | +19.32% | -10.70% | -3.88% | -4.66% | -44.56% | +163.45% | -11.15% | +30.85% | +18.56% | -3.22% | +41.25% | +21.03% | -2.51% | +18.79% | n/a |
Research and Development Revenue | 18.51M | 21.7M | 19.17M | 20.91M | 19.79M | 15.21M | 19.08M | 15.6M | 15.6M | 22.06M | 19.01M | 13.82M | 14.11M | 12.16M | 13.19M | 13.19M | 12.1M | 12.3M | 11.38M | 9.34M | 8.91M | 7.07M | 8.59M | 8.85M | 5.66M | 4.34M | 9.57M | 8.93M | 8.13M | 9.23M | 10.6M | 3.91M | 4.39M | 4.23M | 2.53M |
Research and Development Revenue Growth | -14.69% | +13.19% | -8.32% | +5.67% | +30.12% | -20.29% | +22.31% | 0.00% | -29.29% | +16.04% | +37.57% | -2.07% | +16.04% | -7.78% | -0.04% | +9.00% | -1.58% | +8.06% | +21.83% | +4.84% | +26.13% | -17.74% | -2.99% | +56.57% | +30.18% | -54.62% | +7.19% | +9.80% | -11.89% | -12.93% | +171.40% | -11.05% | +3.88% | +67.14% | n/a |